Bookmark

Add to MyYahoo RSS

Bayer HealthCare News

News on Bayer HealthCare continually updated from thousands of sources around the net.

3 hrs ago | Sys-Con Media

New Data Show Once-Daily XARELTOA May Be an Alternative to Vitamin K ...

Cardioversion requires stable anticoagulation to help prevent life-threatening blood clots before, during and after the procedure.

Comment?

Related Topix: Manufacturing, Chemicals, Heart Attack, Health

Fri Aug 29, 2014

Business Journal

Bayer plans $100 million project in Berkeley - maybe

Bayer HealthCare Pharmaceuticals could spend $100 million to build a product testing facility and raze three buildings in Berkeley, but the drug developer said a final decision on whether to move forward with the project won't come until later this year.

Comment?

Related Topix: Manufacturing, Chemicals, Berkeley, CA

Medical News

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO to include additional high-risk patient populations.

Comment?

Related Topix: Manufacturing, Chemicals, Medicine, Aspirin (generic), Bayer, Alka-Seltzer, Stroke, Health, Healthcare Law, Law

Reuters

UPDATE 1-Germany's Bayer to launch three new Xarelto trials

Germany's Bayer unveiled plans to launch three new studies to expand the uses of its anti-clotting drug Xarelto, one of its top five new medicines.

Comment?

Related Topix: Manufacturing, Chemicals, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Stroke, Health

Reuters

UPDATE 1-Germany's Bayer to launch three new Xarelto trials

Germany's Bayer unveiled plans to launch three new studies to expand the uses of its anti-clotting drug Xarelto, one of its top five new medicines.

Comment?

Related Topix: Manufacturing, Chemicals, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Stroke, Health

Thu Aug 28, 2014

English Dong-A

Son scores in lightening speed

Son scores in lightening speed . AUGUST 29, 2014 03:42. . Bayer 04 Leverkusen striker Son Heung-min expresses his joy and runs after scoring a lightening-fast first goal 69 seconds into the August 28 match in the second playoff of the Union of European Football Associations Champions League against Copenhagen of Denmark.

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals

VentureBeat

Bayer HealthCare starts its own accelerator - and it's better than you expected

Bayer HealthCare appears to be the first pharmaceutical company to have started its own accelerator.

Comment?

Related Topix: Manufacturing, Chemicals, Marketing

Thu Aug 21, 2014

FoodNavigator

Dietary fiber proposals in Nutrition Facts overhaul will create...

FDA proposals that would require the pre-approval of certain fiber ingredients before the agency will count them as 'dietary fibers' on the Nutrition Facts panel are illogical and unfair, claim industry commentators.

Comment?

Related Topix: Healthcare Law, Law, Medicine, Nutrition, Life, Food, Manufacturing, Chemicals

Wed Aug 20, 2014

Freshnews

Quantum Materials Acquires Bayer Technology Services Quantum Dot...

Quantum Materials Corporation today announced the purchase of five diverse sets of patent families from Bayer Technology Services GmbH, the global technological backbone and major innovation driver for Bayer AG of Leverkusen, Germany.

Comment?

Related Topix: Manufacturing, Biotech, Bayer AG, Chemicals, e-Spirit, Pharmaceuticals, World News, Germany

Mon Aug 18, 2014

GlobeNewswire

DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26,...

Bayer Aktiengesellschaft 18.08.2014 13:05 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.

Comment?

Related Topix: Manufacturing, Hannover RckversicherungsAktiengesellschaft, Insurance, Chemicals, World News, Germany

GlobeNewswire

DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26,...

Bayer Aktiengesellschaft 18.08.2014 13:01 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.

Comment?

Related Topix: Manufacturing, Hannover RckversicherungsAktiengesellschaft, Insurance, Chemicals, Sun Life Financial, World News, Germany

GlobeNewswire

DGAP-PVR: Bayer Aktiengesellschaft: Release according to Article 26,...

Bayer Aktiengesellschaft 18.08.2014 13:09 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG.

Comment?

Related Topix: Manufacturing, Hannover RckversicherungsAktiengesellschaft, Insurance, Chemicals, Wellesley-Hills, MA, World News, Germany

Metro

Young Brits admit to using cling film as contraceptive. True story

If the results of a recent survey on contraception are to be believed, some young Brits need to go back to sex ed - ASAP.

Comment?

Related Topix: Human Sexuality, Manufacturing, Chemicals

Fri Aug 15, 2014

Seeking Alpha

CorMedix (CRMD) CEO Randy Milby on Q2 2014 Results - Earnings Call Transcript

All lines have been placed on listen-only mode and the floor will be open for your questions following the presentation.

Comment?

Related Topix: Manufacturing, Chemicals, Infectious Diseases, Marketing

Thu Aug 14, 2014

InvestorIdeas.com

Biotech News Alert: GenSpera (OTCQB:GNSZ) to Present at Rodman &...

August 14, 2014 GenSpera, Inc. , a leader in developing prodrug therapeutics for the treatment of cancer, announces it will be presenting at the Rodman & Renshaw 16th Annual Global Investment Conference.

Comment?

Related Topix: Investment Banking, Financial Services, Rodman and Renshaw, Manufacturing, Chemicals, Startups, Onyx Pharmaceuticals, Amgen

Wed Aug 13, 2014

Medical News Today

European Commission grants EYLEA licence for the treatment of visual...

Bayer HealthCare today announces that EYLEA has been approved by the European Commission for the treatment of visual impairment due to diabetic macular oedema .1 EYLEA is an established treatment for other eye conditions that could now offer patients with DMO significant visual benefits, from start of treatment, without the need for strict monthly ... (more)

Comment?

Related Topix: Manufacturing, Chemicals, Diabetes, Health

Fri Aug 08, 2014

Seeking Alpha

The Case That Regeneron May Be Significantly Undervalued

The combination of high R&D spending and elevated pre-launch expenses for its late-stage cholesterol reducer alirocumab means that P/E is the wrong metric investors should look at.

Comment?

Related Topix: Biotech, Medicine, Regeneron Pharmaceuticals, Healthcare Industry, Celgene, Pharmacology, Manufacturing, Chemicals

Tue Aug 05, 2014

Pharmaceutical Online

Bayer Bags EU Approval For Cancer Drug Stivarga

The European Commission has granted approval to Bayer HealthCare's oncology drug Stivarga for the treatment of patients with unresectable or metastatic gastrointestinal stromal tumors who have progressed or shown intolerance to prior treatment with imatinib and sunitinib.

Comment?

Related Topix: Manufacturing, Chemicals, Medicine, Cancer, Oncology, Sarcoma

Business Journal

Bayer donates $100K to American Red Cross disaster relief programs

Bayer Corp. is giving the American Red Cross $100,000 to help with its disaster relief programs.

Comment?

Related Topix: Manufacturing, Chemicals

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••